November 1, 2016
Advanced Oncotherapy sees board changes
Advanced Oncotherapy has announced that Lord David Evans has stepped down
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
October 31, 2016
French Genfit raises €78.5M, aims to invest in R&D
French Genfit has raised €78.5 million and invests in its R&D
October 31, 2016
Premaitha’s non-invasive prenatal test available on the NHS (UK)
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)
October 31, 2016
Sanofi submits corrective action plan to the FDA regarding the BLA for sarilumab
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
October 31, 2016
Finnish patent office accepts Faron’s new formulation for a respiratory orphan disease ARDS
Finish patent office has accepts Faron’s new formulation for a respiratory orphan disease ARDS
October 27, 2016
Allergan to close down buying Motus, relamorelin goes to Phase 3 tests
Allergan on Thursday announced the results of Phase 2b study of the new gastroparesis…
October 27, 2016
Advanced Oncotherapy promotes Nicolas Serandour as new CEO
Advanced Oncotherapy has named Nicolas Serandour the new CEO…
October 26, 2016
AstraZeneca’s ovarian cancer tablets pass Phase III SOLO-2 trial
AstraZeneca’s Lynparza tablets against BRCA-mutated ovarian cancer have shown…
October 24, 2016
Faron recruits patients for the Japanese Traumakine Phase III trial
Faron Pharmaceuticals (Faron), the clinical stage biopharmaceutical company, has recruited the first patient in the Japanese Phase III pivotal clinical trial for the…
October 20, 2016
Esperite starts developing inflammatory bowel disease therapies; Starts with Crohn`s disease
Esperite`s business unit The Cell Factory in collaboration with Women`s and Children`s Health Department of the University of Padua and the Padua University Hospital are developing therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs).